LLY

Eli Lilly and Company

Healthcare›Drug Manufacturers - General|New York Stock Exchange|US

Price

$935.62

Market Cap

$883.99B

Beta

0.50

P/E

40.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+44.70%

EPS Growth (YoY)+95.99%

Revenue CAGR 3Y+31.69%

P/E Ratio40.6

PEG Ratio0.42

FCF Yield+1.01%

Debt / Equity1.60

Interest Coverage37.3x

No credit card required

Already have an account? Sign in to view the full analysis for LLY.